pepaxti
oncopeptides ab - melphalan flufenamide hydrochloride - myeloma multiplex - daganatellenes szerek - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.
mobilisin kenőcs
sankyo pharma gmbh - flufenamic sav -
dapotum d injekció
pharmavit - flufenazine -
moditen depo 25 mg/ml oldatos injekció
krka d.d., - fluphenazine -
cernevit por oldatos injekcióhoz vagy infúzióhoz
baxter (hungary) kft. - vitaminok -
traumon gél
goodwill pharma kft. - etofenamate -
trittico ac 150 mg retard tabletta
angelini pharma Österreich gmbh - gyógyszer -
hermes cevitt 1000 mg pezsgőtabletta
hermes arzneimittel gmbh - aszkorbinsav -
neo citran belsőleges por felnőtteknek
glaxosmithkline-consumer kft. - fenilefrin; paracetamol; aszkorbinsav; is pheniramine-maleát -
hermes cevitt f 1000 mg pezsgőtabletta
hermes arzneimittel gmbh - aszkorbinsav -